Key strategic initiatives for 2017

Our strategy

Our strategy is to provide wider and cost-effective access to radiation treatment through a ground-breaking proton therapy system with superior clinical benefits for cancer patients.

System development and partner negotiations

We intend to sign partnerships agreements with the key manufacturers and collaborators associated throughout the development of our LIGHT machine.


We will continue to build our expert team. A number of important appointments were already made since the beginning of 2014. Our people are focused on developing the first accelerator and operational LIGHT system as safely and quickly as possible.

New hospital contracts

Because cancer is a global phenomenon with no geographic boundaries, we will continue discussions with existing and new parties, both in the United States and in other regions of the world.


Who we are

We are leaders in the next generation of proton systems which do not require a cyclotron or synchrotron. We develop cost effective treatments which are clinically superior to those currently available.

Read more


We have a strong foundation of core company values which underpin everything we do.

Read more


Our board brings entrepreneurial, commercial and financial leadership.

Read more


Advanced Oncotherapy was created in 2012, leveraging the work and know-how of CERN experts in accelerator and detector technologies.

Read more

Leadership Team

Our team is made up of highly skilled professionals who have a wide range of experience in their field.

Read more


Their expertise and experience are unmatched. Combined they have over 100 years in radiation oncology and over 45 years of treating patients with proton therapy from around the world.

Read more

Corporate governance

Advanced Oncotherapy is committed to the highest standards of corporate governance, business integrity and professionalism. The Directors recognise the importance of sound corporate governance.

Read more


Interviews highlighting the depth and range of experience with Advanced Oncotherapy.

Read more